Your browser doesn't support javascript.
loading
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation.
Hauser, Blake M; Sangesland, Maya; Lam, Evan C; St Denis, Kerri J; Sheehan, Maegan L; Vu, Mya L; Cheng, Agnes H; Sordilla, Sophia; Lamson, Dana Thornlow; Almawi, Ahmad W; Balazs, Alejandro B; Lingwood, Daniel; Schmidt, Aaron G.
Affiliation
  • Hauser BM; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Sangesland M; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Lam EC; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • St Denis KJ; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Sheehan ML; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Vu ML; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Cheng AH; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Sordilla S; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Lamson DT; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Almawi AW; Department of Microbiology, Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Balazs AB; Center for Molecular Interactions, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Lingwood D; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
  • Schmidt AG; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.
ACS Infect Dis ; 10(2): 553-561, 2024 02 09.
Article in En | MEDLINE | ID: mdl-38281136
ABSTRACT
Structure-guided rational immunogen design can generate optimized immunogens that elicit a desired humoral response. Design strategies often center on targeting conserved sites on viral glycoproteins that will ultimately confer potent neutralization. For SARS-CoV-2 (SARS-2), the surface-exposed spike glycoprotein includes a broadly conserved portion, the receptor binding motif (RBM), that is required to engage the host cellular receptor, ACE2. Expanding humoral responses to this site may result in a more potent neutralizing antibody response against diverse sarbecoviruses. Here, we used a "resurfacing" approach and iterative design cycles to graft the SARS-2 RBM onto heterologous sarbecovirus scaffolds. The scaffolds were selected to vary the antigenic distance relative to SARS-2 to potentially focus responses to RBM. Multimerized versions of these immunogens elicited broad neutralization against sarbecoviruses in the context of preexisting SARS-2 immunity. These validated engineering approaches can help inform future immunogen design efforts for sarbecoviruses and are generally applicable to other viruses.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / COVID-19 Limits: Humans Language: En Journal: ACS Infect Dis / ACS infect. dis / ACS infectious diseases Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / COVID-19 Limits: Humans Language: En Journal: ACS Infect Dis / ACS infect. dis / ACS infectious diseases Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States